查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401985

2030 年心室辅助装置市场预测：按产品类型、流量类型、设计、应用、最终用户和地区进行的全球分析

Ventricular Assist Device Market Forecasts to 2030 - Global Analysis By Product Type, Type Of Flow, Design, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球心室辅助装置市场规模为 12.9 亿美元，预计预测期内复合年增长率为 12.8%，到 2030 年将达到 30.1 亿美元。

一种称为心室辅助装置 (VAD) 的机械帮浦被插入体内或体外，以帮助虚弱或故障的心臟将血液泵送到全身。这些设备主要用作心臟移植的桥樑，为不适合移植的患者提供目的地治疗，或者在某些情况下，作为严重心臟衰竭患者康復的桥樑。

根据世界卫生组织（WHO）2021年估计，全球每年有1,790万人死于心血管疾病。这占世界死亡人数的 35%。此外，85% 的心血管疾病死亡是由于心臟病和中风造成的。

慢性病快速增加

进展为心臟衰竭的长期疾病的增加是推动心室辅助装置需求的因素之一。心臟衰竭可由许多慢性疾病引起，包括糖尿病、高血压和冠状动脉疾病。因此，更多的患者将需要先进的心臟治疗。随着导致心臟衰竭的慢性疾病变得越来越普遍，心臟衰竭的治疗变得更加长期和深入。这意味着更多的患者将无限期地需要心臟衰竭治疗，或不会成为心臟移植的候选者，从而推动市场成长。

高成本

心室辅助装置治疗费用高昂，包括后续治疗、外科手术、植入后护理和装置使用费，可能会限制患者的使用。由于费用过高，财务限制可能会阻止某些人接受这种挽救生命的治疗。不同地区和国家的卫生保健系统和经济状况的差异可能导致获得这种治疗方法的机会有差异。此外，在医疗基础设施薄弱或财政资源有限的地区，可能很难接触到需要这种治疗方法的人，这阻碍了市场的成长。

器官衰竭的风险增加

高龄化、生活方式的改变和更频繁的慢性疾病正在增加器官衰竭的可能性，尤其是心臟衰竭，增加了对心室辅助装置和其他先进心臟辅助性治疗的需求。由于器官衰竭，尤其是心臟衰竭的风险增加，更多的人面临严重心臟疾病的风险。患者群的扩大增加了需要这种疗法来治疗晚期心臟衰竭的人数。

设备可靠性和耐用性降低

患者和医生对选择心室辅助装置治疗的信心可能会受到对心室辅助装置寿命和可靠性的担忧的影响。对设备故障或故障的恐惧可能会使患者犹豫或不愿意选择这种治疗方法，这可能会对患者的可接受性产生负面影响。此外，旨在推进心室辅助装置技术的研发计划的投资可能会受到对装置可靠性和耐用性的持续担忧的影响。缺乏资金和缺乏开发新产品的动力可能会阻碍该行业的创新，从而抑制市场成长。

COVID-19 的影响

在疫情高峰期，许多医院和医疗机构在分配资源、优先处理紧急病例和限制不必要的治疗方面面临挑战。心室辅助装置植入和定期后续观察等选择性手术被推迟或推迟，这可能对市场产生了暂时的影响。全球供应链（包括生产和分销）的中断也可能影响了这些零件、设备和相关机械的采购和运输。这些不便会影响心室辅助装置购买和安装的时机。

在预测期内，右心室辅助循环装置领域预计将是最大的。

右心室辅助装置是心室辅助装置（VAD）的一种，专门用于支撑心臟的右心室，右心室辅助装置（RVAD），因此右心室辅助装置细分市场正在经历良好的增长。这将会实现。儘管 RVAD 通常侧重于辅助心臟的右侧，但其他心室辅助装置旨在辅助左心室（左心室辅助装置，LVAD）或双心室（BiVAD）。心室辅助装置正在进行的研究和技术开发的目标是改善患者的治疗结果、减少问题并增强 RVAD 的耐用性，同时解决右心室维护特有的问题。

植入式心室辅助装置预计在预测期内将经历最高的复合年增长率

植入式心室辅助装置领域预计在预测期内复合年增长率最高。称为植入式心室辅助装置 (VAD) 的机械帮浦会透过手术插入体内，以帮助心臟泵血。这些设备为严重心臟衰竭或等待心臟移植的患者提供协助，是心室辅助设备市场不可或缺的一部分。它可以改善严重心臟衰竭患者的生活质量，增强运动能力，减轻心臟衰竭症状，延长存活期。

占有率最大的地区

由于高龄化、生活方式的改变以及心血管疾病发病率的增加，心臟衰竭在该地区变得普遍，预计亚太地区将在预测期内占据最大的市场占有率。由于心臟衰竭患者数量不断增加，对心室辅助装置作为治疗选择的需求不断增加。亚太地区各国正在投资扩大其医疗基础设施，包括现代化尖端心臟护理设施。许多领先的医疗设备製造商都致力于进入和发展亚太地区的这个市场。

复合年增长率最高的地区：

预计欧洲在预测期内的复合年增长率最高，因为与世界许多其他地区一样，心臟衰竭在欧洲变得越来越普遍。随着心臟衰竭患者数量的不断增加，对心室辅助装置作为晚期心臟衰竭患者治疗选择的需求也越来越大。此外，该技术已改进，现已在欧洲市场上销售。持续的技术创新旨在改善患者的治疗效果，减少与心室辅助装置治疗相关的问题，并生产更紧凑、坚固和有效的设备，从而推动市场成长。

免费客製化服务：

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球心室辅助装置市场：依产品类型

  • 右心室辅助装置
  • 左心室辅助装置
  • 双心室辅助装置
  • 全人工心臟

第六章全球心室辅助装置市场：依流量类型

  • 脉动流
  • 连续流

第七章全球心室辅助装置市场：设计

  • 植入式心室辅助装置
  • 经皮心室辅助装置

第八章全球心室辅助装置市场：依应用分类

  • 恢復之桥 (BTR)
  • 目的地治疗 (DT)
  • 移植桥 (BTT)
  • 候选疗法的桥樑（BTC）

第九章全球心室辅助装置市场：依最终使用者分类

  • 医院
  • 家庭护理设置
  • 门诊治疗中心
  • 其他最终用户

第十章全球心室辅助装置市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Corewave SA
  • SynCardia Systems
  • AdjuCor GmbH
  • Bivacor Inc
  • LivaNova PLC
  • Windmill Cardiovascular Systems
  • Calon Cardio-Technology Ltd
  • Abiomed, Inc.
  • Fineheart
  • Abbott Laboratories
  • Evaheart, Inc.,
  • Berlin Heart GmbH
  • Carmat SA
  • Medtronic
  • Jarvik Heart, Inc.
  • ReliantHeart
  • Sun Medical Technology Research Corp
  • Thoratec Corporation
  • CardiacAssist, Inc
Product Code: SMRC24505

According to Stratistics MRC, the Global Ventricular Assist Device Market is accounted for $1.29 billion in 2023 and is expected to reach $3.01 billion by 2030 growing at a CAGR of 12.8% during the forecast period. A mechanical pump called a Ventricular Assist Device (VAD) is inserted either within or outside the body to help a weak or failing heart pump blood throughout the body. These devices are mostly used as a bridge to heart transplantation, destination treatment for patients not suitable for transplantation, or, in certain circumstances, as a bridge to recovery in patients with severe heart failure.

According to the World Health Organization 2021, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke.

Market Dynamics:

Driver:

Surge in the prevalence of chronic conditions

An increase in long-term illnesses that lead to advanced heart failure is one factor driving up demand for ventricular assist device. Heart failure can be caused by a number of chronic illnesses, including diabetes, hypertension, and coronary artery disease. As a result, more individuals will need sophisticated cardiac care. Heart failure care may need to be longer and more intensive if chronic diseases that contribute to heart failure are more common. This may mean that more patients may need this therapy indefinitely, or that more patients who are not candidates for heart transplantation will need thus driving the growth of the market

Restraint:

High cost

Patients' access may be restricted by the high cost of ventricular assist device therapy, which includes follow-up therapies, surgical procedures, post-implantation care, and device fees. Financial limitations may impede certain persons from accessing this life-saving therapy because of its exorbitant expenses. Variations in healthcare systems and economic situations among various areas or nations may give rise to disparities in the accessibility of this treatment. Moreover, this treatment may be difficult to get to those in need in areas with a poor healthcare infrastructure or low financial resources which hamper the market growth.

Opportunity:

Increasing risks of organ failures

Ventricular Assist Device and other advanced cardiac support therapies are in greater demand as the chances of organ failures, particularly cardiac failure, and rise owing to aging populations, changing lifestyles, and the frequency of chronic illnesses. An increasing number of people are at risk for serious cardiac disorders due to the rising risks of organ failure, particularly heart failure. The number of people who would need this treatment to treat advanced heart failure rises as a result of this patient pool expansion.

Threat:

Compromised device reliability and durability

Patients' and doctors' confidence in selecting ventricular assist device therapy may be impacted by worries regarding the longevity and dependability of the device. Fear of device failure or malfunction may cause patients to hesitate or be reluctant to choose this treatment, which may have an adverse effect on patient acceptability. Furthermore, investment in R&D projects targeted at advancing VAD technology may be impacted by enduring worries about the dependability and durability of the devices. Innovation in the industry may be hampered by a lack of funding or a decline in enthusiasm in creating new gadgets impeding the market growth.

COVID-19 Impact

Many hospitals and healthcare institutions encountered difficulties in allocating resources, giving priority to urgent cases, and curtailing non-essential treatments during the peak times of the epidemic. It's possible that elective procedures, such as certain ventricular assist device implantations or regular follow-ups, were postponed or delayed, which momentarily affected the market. Disruptions in the worldwide supply chain, including production and delivery, may have affected the accessibility and conveyance of these parts, apparatus, or associated machinery. These hiccups can have an impact on when ventricular assist device are purchased and installed.

The right ventricular assist device segment is expected to be the largest during the forecast period

The right ventricular assist device segment is estimated to have a lucrative growth, as it one kind of Ventricular Assist Device (VAD) made expressly to support the right ventricle of the heart is the Right Ventricular Assist Device (RVAD). The RVAD is generally focused on helping the right side of the heart, while other VADs are designed to support the left ventricle (Left Ventricular support Device, or LVAD) or both ventricles (BiVAD). The goal of ongoing research and technological developments in VADs is to improve patient outcomes, decrease problems, and strengthen the endurance of RVADs while addressing issues unique to sustaining the right ventricle.

The implantable ventricular assist device segment is expected to have the highest CAGR during the forecast period

The implantable ventricular assist device segment is anticipated to witness the highest CAGR growth during the forecast period. Mechanical pumps called Implantable Ventricular Assist Devices (VADs) are surgically inserted within the body to help the heart pump blood. These devices, which provide assistance to those with severe heart failure or that awaiting heart transplantation, are an essential part of the market for ventricular assist devices. The quality of life is enhanced, exercise capacity is boosted, heart failure symptoms are relieved, and patients with severe heart failure have a longer chance of survival due to these devices.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period as heart failure is becoming more common in the Asia Pacific area as a result of aging populations, changes in lifestyle, and an increase in cardiovascular disorders. The increased need for ventricular assist device as a therapy option is a result of the rise in heart failure cases. Every nation in the Asia-Pacific area is making investments in the expansion of its healthcare infrastructure, including modernizing its facilities for cutting-edge cardiac treatment. A number of major medical device companies have been concentrating on joining and growing in the Asia Pacific this market.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, because heart failure is becoming more common in Europe, as it is in many other parts of the world. The need for ventricular assist device as a therapy option for individuals with advanced heart failure has increased as a result of the growth in heart failure cases. Moreover, this technology has been improving and is now available in the European market. Constant innovation aims to improve patient outcomes, lower problems related to VAD therapy, and create more compact, robust, and effective devices driving the growth of the market.

Key players in the market:

Some of the key players profiled in the Ventricular Assist Device Market include Corewave SA, SynCardia Systems, AdjuCor GmbH, Bivacor Inc, LivaNova PLC, Windmill Cardiovascular Systems, Calon Cardio-Technology Ltd, Abiomed, Inc., Fineheart, Abbott Laboratories, Evaheart, Inc.,Berlin Heart GmbH, Carmat SA, Medtronic, Jarvik Heart, Inc., ReliantHeart, Sun Medical Technology Research Corp, Thoratec Corporation and CardiacAssist, Inc

Key Developments:

In November 2023, Sun Medical Technology Research Corp. announced that it has received ¥2 billion in funding from Hi-Lex Corporation. The investor will hold 66.7% stake in the company through this transaction.

In September 2023, CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris. The company occupies over 2,400m² of production, laboratory, and office space, bringing together its headquarters, R&D center and its first manufacturing facility of almost 1,000m².

Product Types Covered:

  • Right Ventricular Assist Device
  • Left Ventricular Assist Device
  • Bi-Ventricular Assist Device
  • Total Artificial Heart

Type Of Flows Covered:

  • Pulsatile Flow
  • Continuous Flow

Designs Covered:

  • Implantable Ventricular Assist Device
  • Transcutaneous Ventricular Assist Device

Applications Covered:

  • Bridge-To-Recovery (BTR)
  • Destination Therapy
  • Bridge-To-Transplant (BTT)
  • Bridge To Candidacy Therapy

End Users Covered:

  • Hospitals
  • Home Care Setups
  • Ambulatory Care Center
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ventricular Assist Device Market, By Product Type

  • 5.1 Introduction
  • 5.2 Right Ventricular Assist Device
  • 5.3 Left Ventricular Assist Device
  • 5.4 Bi-Ventricular Assist Device
  • 5.5 Total Artificial Heart

6 Global Ventricular Assist Device Market, By Type Of Flow

  • 6.1 Introduction
  • 6.2 Pulsatile Flow
  • 6.3 Continuous Flow

7 Global Ventricular Assist Device Market, By Design

  • 7.1 Introduction
  • 7.2 Implantable Ventricular Assist Device
  • 7.3 Transcutaneous Ventricular Assist Device

8 Global Ventricular Assist Device Market, By Application

  • 8.1 Introduction
  • 8.2 Bridge-To-Recovery (BTR)
  • 8.3 Destination Therapy
  • 8.4 Bridge-To-Transplant (BTT)
  • 8.5 Bridge To Candidacy Therapy

9 Global Ventricular Assist Device Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Home Care Setups
  • 9.4 Ambulatory Care Center
  • 9.5 Other End Users

10 Global Ventricular Assist Device Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Corewave SA
  • 12.2 SynCardia Systems
  • 12.3 AdjuCor GmbH
  • 12.4 Bivacor Inc
  • 12.5 LivaNova PLC
  • 12.6 Windmill Cardiovascular Systems
  • 12.7 Calon Cardio-Technology Ltd
  • 12.8 Abiomed, Inc.
  • 12.9 Fineheart
  • 12.10 Abbott Laboratories
  • 12.11 Evaheart, Inc.,
  • 12.12 Berlin Heart GmbH
  • 12.13 Carmat SA
  • 12.14 Medtronic
  • 12.15 Jarvik Heart, Inc.
  • 12.16 ReliantHeart
  • 12.17 Sun Medical Technology Research Corp
  • 12.18 Thoratec Corporation
  • 12.19 CardiacAssist, Inc

List of Tables

  • Table 1 Global Ventricular Assist Device Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
  • Table 4 Global Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
  • Table 5 Global Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
  • Table 6 Global Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
  • Table 7 Global Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
  • Table 8 Global Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
  • Table 9 Global Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
  • Table 10 Global Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
  • Table 11 Global Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
  • Table 12 Global Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
  • Table 13 Global Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 Global Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
  • Table 15 Global Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
  • Table 16 Global Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
  • Table 17 Global Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
  • Table 18 Global Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 20 Global Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
  • Table 21 Global Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
  • Table 22 Global Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 25 North America Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
  • Table 26 North America Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
  • Table 27 North America Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
  • Table 28 North America Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
  • Table 29 North America Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
  • Table 30 North America Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
  • Table 31 North America Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
  • Table 32 North America Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
  • Table 33 North America Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
  • Table 34 North America Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
  • Table 35 North America Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
  • Table 37 North America Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
  • Table 38 North America Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
  • Table 39 North America Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
  • Table 40 North America Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 North America Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 42 North America Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
  • Table 43 North America Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
  • Table 44 North America Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 47 Europe Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
  • Table 48 Europe Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
  • Table 49 Europe Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
  • Table 50 Europe Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
  • Table 51 Europe Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
  • Table 52 Europe Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
  • Table 53 Europe Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
  • Table 54 Europe Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
  • Table 55 Europe Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
  • Table 56 Europe Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
  • Table 57 Europe Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Europe Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
  • Table 59 Europe Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
  • Table 60 Europe Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
  • Table 61 Europe Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
  • Table 62 Europe Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
  • Table 63 Europe Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 64 Europe Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
  • Table 65 Europe Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
  • Table 66 Europe Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
  • Table 70 Asia Pacific Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
  • Table 71 Asia Pacific Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
  • Table 72 Asia Pacific Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
  • Table 73 Asia Pacific Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
  • Table 74 Asia Pacific Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
  • Table 75 Asia Pacific Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
  • Table 76 Asia Pacific Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
  • Table 77 Asia Pacific Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
  • Table 78 Asia Pacific Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
  • Table 79 Asia Pacific Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
  • Table 80 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
  • Table 81 Asia Pacific Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
  • Table 82 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
  • Table 83 Asia Pacific Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
  • Table 84 Asia Pacific Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
  • Table 85 Asia Pacific Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 86 Asia Pacific Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
  • Table 87 Asia Pacific Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
  • Table 88 Asia Pacific Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 91 South America Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
  • Table 92 South America Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
  • Table 93 South America Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
  • Table 94 South America Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
  • Table 95 South America Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
  • Table 96 South America Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
  • Table 97 South America Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
  • Table 98 South America Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
  • Table 99 South America Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
  • Table 100 South America Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
  • Table 101 South America Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
  • Table 102 South America Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
  • Table 103 South America Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
  • Table 104 South America Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
  • Table 105 South America Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
  • Table 106 South America Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
  • Table 107 South America Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 108 South America Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
  • Table 109 South America Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
  • Table 110 South America Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Ventricular Assist Device Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Ventricular Assist Device Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Ventricular Assist Device Market Outlook, By Right Ventricular Assist Device (2021-2030) ($MN)
  • Table 114 Middle East & Africa Ventricular Assist Device Market Outlook, By Left Ventricular Assist Device (2021-2030) ($MN)
  • Table 115 Middle East & Africa Ventricular Assist Device Market Outlook, By Bi-Ventricular Assist Device (2021-2030) ($MN)
  • Table 116 Middle East & Africa Ventricular Assist Device Market Outlook, By Total Artificial Heart (2021-2030) ($MN)
  • Table 117 Middle East & Africa Ventricular Assist Device Market Outlook, By Type Of Flow (2021-2030) ($MN)
  • Table 118 Middle East & Africa Ventricular Assist Device Market Outlook, By Pulsatile Flow (2021-2030) ($MN)
  • Table 119 Middle East & Africa Ventricular Assist Device Market Outlook, By Continuous Flow (2021-2030) ($MN)
  • Table 120 Middle East & Africa Ventricular Assist Device Market Outlook, By Design (2021-2030) ($MN)
  • Table 121 Middle East & Africa Ventricular Assist Device Market Outlook, By Implantable Ventricular Assist Device (2021-2030) ($MN)
  • Table 122 Middle East & Africa Ventricular Assist Device Market Outlook, By Transcutaneous Ventricular Assist Device (2021-2030) ($MN)
  • Table 123 Middle East & Africa Ventricular Assist Device Market Outlook, By Application (2021-2030) ($MN)
  • Table 124 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge-To-Recovery (BTR) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Ventricular Assist Device Market Outlook, By Destination Therapy (2021-2030) ($MN)
  • Table 126 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge-To-Transplant (BTT) (2021-2030) ($MN)
  • Table 127 Middle East & Africa Ventricular Assist Device Market Outlook, By Bridge To Candidacy Therapy (2021-2030) ($MN)
  • Table 128 Middle East & Africa Ventricular Assist Device Market Outlook, By End User (2021-2030) ($MN)
  • Table 129 Middle East & Africa Ventricular Assist Device Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 130 Middle East & Africa Ventricular Assist Device Market Outlook, By Home Care Setups (2021-2030) ($MN)
  • Table 131 Middle East & Africa Ventricular Assist Device Market Outlook, By Ambulatory Care Center (2021-2030) ($MN)
  • Table 132 Middle East & Africa Ventricular Assist Device Market Outlook, By Other End Users (2021-2030) ($MN)